| Similar Articles |
|---|
 |
The Motley Fool
August 4, 2004
Roger Nusbaum |
Inamed Waiting for Good News This multifaceted medical device company, which sells breast implants, awaits an FDA decision. The biggest risk is the stock getting caught in a general health sector downturn.   |
BusinessWeek
December 25, 2006
Palmeri & Weintraub |
Silicone Goes Subtle Allergan's campaign relies on friendly persuasion. |
The Motley Fool
January 31, 2007
Brian Lawler |
No Earnings Face-Lift Needed For Allergan The ophthalmic and plastic surgery product developer has made many investors rich, and it's not stopping now. |
The Motley Fool
April 14, 2005
Rich Duprey |
Mentor the Winner on Implants An FDA panel gives Mentor the right to market breast implants after denying Inamed's application. On the news, Inamed's stock fell by more than 3%, and then nearly 7% in early morning trading. |
BusinessWeek
April 25, 2005
Catherine Arnst |
Breast Implants: Science vs. Emotion Lobbying and politics are having a huge effect on the debate over whether to allow silicone breast implants back on the market. |
The Motley Fool
December 16, 2005
Stephen D. Simpson |
A Romantic Rectangle in Health Care First Medicis wants Inamed, then Allergan wants Inamed. Now Mentor wants Medicis. Strange days in health care, to be sure. Investors, take note. |
The Motley Fool
May 19, 2006
Jim Mueller |
Foolish Forecast: Mentor's Uncertain Results Factors outside of the cosmetic surgery products maker's control are leading to short-term uncertainty. Investors, take note. |
The Motley Fool
August 8, 2006
Stephen D. Simpson |
Waiting on Fine Figures From Mentor Flush with cash, medical aesthetics specialist Mentor needs to reinvest in growth. This is a fine company that rarely trades cheap -- investors, take note. |
The Motley Fool
January 23, 2004
Jean Graham |
Keeping Abreast of Implants Inamed's race with Mentor for first rights to the silicone breast implant market hits a snag. |
The Motley Fool
May 27, 2009
Brian Orelli |
A Wrinkle in the Botox Plan The FDA turns down Allergan's label expansion, but it wasn't all bad news. |
The Motley Fool
February 9, 2006
Stephen D. Simpson |
Mentor Needs Some Prettying Up Until new products are approved or acquired, the aesthetics and urology company seems stuck in suspended animation. Just standing in place is not going to build much shareholder value. |
Salon.com
October 9, 2000
Denise Dowling |
Covering up the breast The National Cancer Institute decides not to publicize the results of a publicly funded study of the safety of silicone breast implants. What's the deal? |
Chemistry World
August 1, 2006
Victoria Gill |
Breast Implant Study `Probably Flawed' The editors of a journal that published a study linking silicone breast implants with higher than normal levels of platinum in the circulation have urged caution when interpreting the findings. |
The Motley Fool
September 12, 2008
Brian Lawler |
A New Wrinkle for an Old Drug Allergan's muscle relaxant Botox performs well in two studies testing its ability to prevent migraine headaches. |
BusinessWeek
March 25, 2010
Elizabeth Lopatto |
And Now, Gastric Surgery for Kids Allergan wants to market its Lap-Band implants for younger obese patients, but some doctors are balking |
The Motley Fool
June 5, 2008
Brian Lawler |
Allergan Lashes Out The pharmaceutical announces a new drug that could promote eyelash growth. |
AskMen.com
Dustin Driver |
Male Plastic Surgery If you're thinking about surgical body modifications, keep reading. The following procedures can be performed in a matter of hours by a skilled plastic surgeon. |
BusinessWeek
October 13, 2003
Arlene Weintraub |
He Bet on Botox -- And Won David Pyott transformed sleepy Allergan. Where is he taking its blockbuster drug? |
The Motley Fool
December 15, 2003
Alyce Lomax |
No Wrinkles for Medicis Medicis Pharmaceuticals announced that the FDA has approved its injectable wrinkle-filling gel, Restylane. Allergan's Botox has found a new competitor in the fountain-of-youth market. |
Chemistry World
April 29, 2014
Phillip Broadwith |
Valeant launches hostile bid for Allergan US drugmaker Valeant has lined up its next takeover target: Botox provider Allergan. Valeant has taken its proposal direct to shareholders, but Allergan has activated a 'poison pill' defense to buy time. |
Health
January 5, 2010
Susan Hall |
Thinking About Cosmetic Surgery? Here's How to Get a Better Nip or Tuck We reveal what it's like to have the three most popular procedures and whether those money-saving alternatives people talk about are worth it. |
CRM
February 2003
David Myron |
Support Gets a Face-Lift Allergan was able to automate the routing of 80 percent of all inbound, Web-generated emails, based on the business rules the company put in place. |
The Motley Fool
January 15, 2009
Robert Steyer |
Medicis Tries to Save Face The wrinkle-removal drugmaker hopes it can smooth out a tough economy. |
The Motley Fool
May 6, 2009
Robert Steyer |
Getting Ahead by Getting Rid of Wrinkles Medicis gets the FDA OK for an anti-wrinkle product as the market for Botox and other cosmetic skin drugs sags. |
The Motley Fool
March 21, 2005
Rich Duprey |
Inamed Buoyant on Medicis Buyout Breast-implant maker Inamed will be acquired in a $2.8 billion deal with skin-care pharmaceutical Medicis. Inamed investors should now decide whether they want to be a part of Medicis or enjoy the profits realized from the offer. |
The Motley Fool
June 3, 2004
Mark Mahorney |
Breast Enhancer Bounces Back Dow Corning emerges from bankruptcy after nine years spent protecting itself from several hundred thousand suing women who claimed that ruptured silicone breast implants made by the company were the cause of autoimmune diseases. Now what? |
The Motley Fool
October 7, 2009
Jim Mueller |
Daily Walk of Shame: Money-Hungry Drugmakers If Allergan wins its suit against the government, consumers will really be in trouble. |
Chemistry World
January 25, 2013
Andrew Turley |
Allergan buys MAP for $958m Allergan, best known as the company behind Botox (onabotulinumtoxin A) injections, has agreed to buy US drug maker MAP Pharmaceuticals for $958 million |
AskMen.com
Austin Silver |
Celebrities & Cosmetic Surgery What is happening in today's society? It seems that the most fashionable thing among celebrities is plastic surgery. Everything from tummy tucks and chin implants to eye lifts and breast implants have taken effect more than ever. |
The Motley Fool
September 20, 2007
Brian Lawler |
Allergan's Overactive Acquisition Specialty pharma Allergan announced yesterday that it is acquiring privately held Esprit Pharma for $370 million in an all-cash transaction. Investors, take note. |
The Motley Fool
December 1, 2008
Brian Orelli |
Johnson & Johnson Firms Things Up The health-care giant acquires breast-implant maker Mentor. |
The Motley Fool
March 2, 2011
Susmita Chatterjee |
How to Capitalize on the Obesity Epidemic Does broader use of Allergan's Lap-Band signify competition for others? |
CIO
December 14, 2010
Kim S. Nash |
How Botox Battles Compliance Wrinkles A BPM overhaul saved the day after legal issues complicated compliance at Botox-maker Allergan. |
Health
February 19, 2009 |
Do You Need a Breast Reduction? The number of women opting for breast reductions has jumped 25% in recent years -- to 106,000 in the latest annual count by the American Society of Plastic Surgeons. |
Chemistry World
June 10, 2008
James Mitchell Crow |
A Drug for Longer Lashes? US drugmaker Allergan, the California-based company that makes antiwrinkle treatment Botox, has developed a new cosmetic drug that makes eyelashes grow longer, thicker and darker. |
Chemistry World
June 24, 2015
Matthew Gunther |
Allergan to buy out Kythera Biopharma for $2.1bn The pharma firm Allergan will acquire Kythera Biopharmaceuticals in a $2.1 billion deal. |
Salon.com
March 2, 2001
Dawn MacKeen |
Your heart has been recalled In the brave new world of body-part implants, what happens when you get a lemon of a ticker? |
The Motley Fool
December 29, 2008
Brian Orelli |
Thicker Lashes, Fatter Wallets The Food and Drug Administration approves Allergan's Latisse, a treatment for sparse eyelashes. |
Reactive Reports
Issue 43
David Bradley |
Polymer Technology Saves Face PolyHap readily bonds with bone with no adverse side effects. The material might ultimately replace titanium in prosthetics and bone repair surgery. The material is currently undergoing clinical trials in Moscow. |
Fast Company
November 2010
Susan Evans |
Exporting Your Plastic Surgery: Lifescience Alley Conference and Expo The number of people jumping on a plane to go under the knife is surging - in the U.S. alone, medical tourism is growing 35% each year. Plastic surgery, which makes up one-third of these trips, will be much discussed at this Minneapolis expo. Here, we look at where people go to get pretty. |
The Motley Fool
April 26, 2005
Stephen D. Simpson |
Growth Is Knee-High Zimmer turns in another fine quarter, with strength in knee implants leading the way. |
BusinessWeek
April 25, 2005
Catherine Arnst |
When Patients Say: Don't Ban My Drug Emotional lobbying can keep a treatment on the market despite serious side effects. |
American Family Physician
October 1, 2000 |
Breast Pain in Women What causes breast pain?... How can my doctor find the cause of my breast pain?... |
The Motley Fool
May 8, 2009
Brian Orelli |
Investing Against Breast Cancer Many companies are interested in both a cure and a large lucrative market. Which are the best investments now in this sector? |
| AskMen.com |
Ill-Gotten Gains Authorities say a Texas woman lied about having breast cancer and spent $10,000 raised at a benefit to have her breasts enlarged. |
Chemistry World
July 28, 2014
Andy Extance |
Takeover battle pushes Allergan to cut R&D jobs Despite a quarterly sales increase it describes as its strongest ever, Botox maker Allergan is laying off 1500 staff as it seeks to fend off a hostile takeover. |
Outside
February 2005 |
Globe-Trekking Gear Myopic adventurers, rejoice... Javelin... Samsung SCH-S250... |
ifeminists
October 29, 2002
Tresa McBee |
Men join women in the quest for perfection Men are finally feeling inadequate enough to scar their bodies. Call it operating-room equality. Some 1 million men chose elective cosmetic surgery last year to reshape noses, suck out fat, de-droop eyelids, transplant new hair and reduce breasts. |
